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T he importance of maintaining normothermia hasbeen a fundamental premise in the neonatal and car-
diac intensive care unit for many years. This has led to
the application of aggressive surface rewarming for
even modest degrees of hypothermia, such as occurs
frequently, for example, after hypothermic cardiopul-
monary bypass (CPB). However, the benefits and risks
of this practice have not been thoroughly studied in
patients who have sustained a hypoxic-ischemic insult,
such as hypothermic circulatory arrest. Furthermore
brain temperature has been reported to increase after
cerebral ischemia, despite normal ambient and core
body temperature.1-3 Such hyperthermic episodes have
been implicated in the exacerbation of neurologic
injury.4 Recently, several rodent studies have suggested
that mild hypothermia (2°-3°C) introduced early after
Background: Aggressive surface warming is a common practice in the
pediatric intensive care unit. However, recent rodent data emphasize the
protective effect of mild (2°-3°C) hypothermia after cerebral ischemia.
This study evaluates different temperature regulation strategies after
deep hypothermic circulatory arrest with a survival piglet model.
Methods: Fifteen piglets were randomly assigned to 3 groups. All groups
underwent 100 minutes of deep hypothermic circulatory arrest at 15°C.
Brain temperature was maintained at 34°C for 24 hours after car-
diopulmonary bypass in group I, 37°C in group II, and 40°C in group
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bation by neurologic deficit score (0, normal; 500, brain death) and
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examination was assessed for hypoxic-ischemic injury (0, normal; 5,
necrosis) in a blinded fashion. Results: All results are expressed as mean
± standard deviation. Recovery of neurologic deficit score (12.0 ± 17.8,
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III cortex) were significantly worse in hyperthermic group III. These
findings were associated with a significantly lower cytochrome aa3
recovery determined by near-infrared spectroscopy in group III animals
(P = .0041 for group I vs III). No animal recovered to baseline elec-
troencephalographic value by 48 hours after deep hypothermic circula-
tory arrest. Recovery was significantly delayed in the hyperthermic
group III animals, with a lower amplitude 14 hours after the operation,
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mic circulatory arrest and should therefore be avoided. (J Thorac
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ischemic injury to the brain provides a neuroprotective
effect.5-7 In addition, the beneficial effects of some neu-
roprotective agents have been found to be related to
their induction of hypothermia.8
Methods
Experimental preparation. Details of the surgical instru-
mentation in the survival piglet model have been described
elsewhere.9 Five-week-old Yorkshire piglets weighing 9.1 ±
1.1 kg were sedated with intraperitoneal methohexital sodium
(45 mg/kg) and intubated with a 5F endotracheal tube. Each
animal was supported with a pressure control ventilator
(Healthdyne model 105; Healthdyne Technologies, Marietta,
Ga) at a peak inspiratory pressure of 20 cm H2O, an inspired
oxygen fraction of 21%, and a rate of 12 to 13 breaths/min to
achieve normal pH and arterial carbon dioxide tension.
Cutaneous electroencephalographic leads were then placed
and secured with collodion, and electroencephalographic
recording was started. After an intravenous bolus of fentanyl
(25 µg/kg) and pancuronium (0.2 mg/kg), anesthesia was
maintained with a continuous infusion of fentanyl (25
m g/kg/h), midazolam (0.2 mg/kg/h), and pancuronium (0.2
mg/kg/h) throughout the entire experiment and for 24 hours
after the operation except during the period of deep hypother-
mic circulatory arrest (DHCA). A 1-mm diameter brain tem-
perature probe was implanted randomly in the left or right
posterior lateral cerebral hemisphere through a small burr-
hole incision. Precautions were taken to ensure that the tem-
perature probe was consistently placed 3 cm from the midline
and 2 cm deep in the parietal cortex in each animal.
Esophageal and rectal temperatures were monitored simulta-
neously throughout the entire experiment. A pair of near-
infrared spectroscopic (NIRS) fiber-optic optodes were
secured to the head with collodion over the frontal lobes, with
an interoptode distance of 3 cm. Baseline electroencephalo-
graphic and NIRS tracings were recorded during 10 minutes
before surgical instrumentation while the animal was main-
tained at an esophageal temperature of 37.0° to 37.5°C.
All surgical procedures were performed under sterile con-
ditions. Arterial blood pressure was monitored before the
operation and for 24 hours after the operation by cannulation
of a superficial branch of the left femoral artery. The right
femoral artery was then exposed in preparation for CPB arte-
rial cannulation. A right anterolateral thoracotomy was per-
formed in the third intercostal space to prepare the right atrium
for venous cannulation. After systemic heparinization (300
IU/kg), an 8F arterial cannula (Medtronic Bio-Medicus,
Minneapolis, Minn) and 24F venous cannula (Bard, Inc, USCI
Division, Billerica, Mass) were inserted into the right femoral
artery and right atrium, respectively. All animals underwent
30 minutes of cooling to 15°C and 100 minutes of DHCA,
followed by 40 minutes of reperfusion. The extent of rewarm-
ing was determined according to the protocol assigned in a
random fashion. Intravenous protamine (5 mg/kg) was
administered after rewarming and weaning from CPB. After
decannulation and closure of all incisions, all animals were
mechanically ventilated for 24 hours, fully sedated, and par-
alyzed while the core temperature was regulated by a warm-
ing-cooling blanket, room temperature, a heating lamp, or all
3 to achieve the desired cerebral temperature determined by
the experimental protocol.
All animals received humane care in compliance with
the “Principles of Laboratory Animal Care” formulated by
the National Society for Medical Research and the “Guide for
the Care and Use of Laboratory Animals” prepared by the
Institute of Laboratory Animal Resources and published by
the National Institutes of Health (NIH publication No 86-23,
revised 1985).
Experimental groups. Fifteen piglets (n = 5 animals/group)
were randomly assigned to 3 groups. In group I the brain tem-
perature was maintained at 34°C, in group II at 37°C, and in
group III at 40°C after CPB and for 24 hours after the
operation.
CPB. The CPB circuit consisted of a roller pump (Cardio-
vascular Instrument Corp, Wakefield, Mass), sterile tubing
(Oslo Medical Sales, Inc, Ashland, Mass) with a 40-m m arte-
rial filter (Pediatric extracorporeal blood filter; PALL
Biomedical, Inc, East Hills, NY), and a membrane oxygena-
tor (VPCML plus; COBE Cardiovascular, Inc, Arvada, Colo).
The priming solution was identical in all 3 groups and con-
sisted of fresh heparinized blood obtained from a donor ani-
mal harvested on the same day of operation and diluted with
crystalloid solution (Normosol, pH 7.4) to achieve a hemat-
ocrit value of 25%. Cefazolin sodium (25 mg/kg), methyl-
prednisolone sodium succinate (30 mg/kg), furosemide (0.25
mg/kg), and sodium bicarbonate (10 mL) were added to the
prime. After baseline recording of all parameters was com-
pleted, systemic heparinization, cannulation, and connection
of the CPB circuit were carried out. CPB was initiated at a
flow rate of 100 mL/kg/min with the pH-stat strategy. Esopha-
geal temperature was cooled to 15°C during 30 minutes
before establishment of CPB.
Furosemide (0.2 mg/kg), mannitol (0.5 g/kg), and sodium
bicarbonate (10 mL) were administered into the pump imme-
diately on reperfusion. Each animal was warmed during 40
minutes at a flow rate of 100 mL/kg/min to achieve a brain
temperature determined by the protocol. The heart was
defibrillated as necessary at 25°C, and blood was transfused to
keep the hematocrit value at least 25% in all groups.
Mechanical ventilation was restarted 10 minutes before wean-
ing from CPB with 100% inspired oxygen fraction. When
hemodynamic stability was confirmed, each animal was taken
off CPB and decannulated, and intravenous protamine was
administered. All incisions were closed under sterile condi-
tions. Continuous NIRS and electroencephalographic data
were recorded for 3 hours and for 48 hours, respectively, after
the operation.
Postoperative management. All animals were monitored
hemodynamically and remained fully sedated, paralyzed, and
mechanically ventilated for the first 24 hours after the opera-
tion, at which time chest tubes were removed and the animals
were weaned and extubated. Maintenance intravenous fluid
was administered through the first postoperative day (POD),
and additional fluid was given to keep the hematocrit value
above 25%.
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Data collection
Body weight. Baseline body weight was recorded before
the operation. Weight measurements were repeated 3 hours,
24 hours, and 4 days after the operation.
Bioelectric impedance index. The total body water content
(TBWC) was estimated by the bioelectric impedance (BEI),
where TBWC a Height2/BEI was calculated by the following
equation: BEI = (Resistance2 + Reactance2)1⁄2. BEI (resis-
tance) has a reciprocal relation with TBWC because of high-
er conductivity of water in the biologic system. The resis-
tance and reactance were measured immediately before and
repeated at 3 hours, 24 hours, and 4 days after the operation.
Blood analysis. Blood samples were collected before the
operation and 24 hours after the operation. Complete blood
cell count and biochemical tests for electrolytes, aspartate
transaminase, alanine aminotransferase, lactate dehydroge-
nase, alkaline phosphate, creatine kinase, total bilirubin, and
blood urea nitrogen were measured.
Electroencephalographic analysis. A baseline electroen-
cephalogram was recorded 10 minutes before the operation
and for 48 hours after the operation. The amplitude and fre-
quency at 14 and 48 hours, as well as seizure activity, were
evaluated and compared between groups by a trained elec-
troencephalographer. Seizures were defined by the presence
of increased amplitude (>15 m V), frequency (>30 Hz), and
morphologic evolution of the electroencephalographic trac-
ing, as well as the absence of movement artifact or voluntary
motor activities on the monitor screen that lasted longer than
10 seconds.
Near-infrared spectroscopy. Techniques and details of spec-
troscopic analysis have been established from previous stud-
ies and described elsewhere.10 In brief, NIRS scanning mea-
sures relative changes in tissue chromophore concentration
with a noninvasive optical method. With the use of appropri-
ate wavelengths, NIRS scanning provides information on the
relative concentrations of oxygenated and deoxygenated
hemoglobin, as well as the redox state of cytochrome aa3,
which is the terminal enzyme of the electron transport chain.
Table I. Experimental conditions
Group I Group II Group III P values P values P values 
(mean ±SD) (mean ±SD) (mean ±SD) (I vs II) (I vs III) (II vs III)
Preoperative body weight (kg) 9.0 ± 1.1 9.5 ± 1.4 8.7 ± 1.7 .56 .76 .38
Hematocrit (%)
On CPB 25.0 ± 1.6 25.0 ± 2.2 25.6 ± 2.1 1.00 .64 .64
Rewarming 26.8 ± 2.8 25.8 ± 2.3 26.8 ± 2.5 .88 .56 .47
3 h off CPB 26.8 ± 2.8 26.6 ± 1.1 25.2 ± 1.6 .88 .22 .28
24 h off CPB 26.2 ± 1.3 29.0 ± 2.6 29.6 ± 3.9 .14 .08 .74
Esophageal temperature (°C)
Baseline 37.3 ± 0.7 37.0 ± 0.7 37.5 ± 1.4 .67 .78 .48
DHCA 16.0 ± 1.5 16.0 ± 1.7 15.2 ± 2.3 .99 .53 .52
40 min rewarming 33.3 ± 1.6 36.0 ± 0.8 37.5 ± 1.1 .004* .0001* .07
3 h off CPB 32.8 ± 0.9 35.9 ± 1.0 37.6 ± 1.3 .0006* .0001* .03
24 h off CPB 35.6 ± 1.3 36.2 ± 0.3 38.8 ± 0.4 .21 .0001* .0003*
Rectal temperature (°C)
Baseline 36.6 ± 1.1 36.6 ± 0.8 37.6 ± 1.0 .97 .15 .14
DHCA 20.3 ± 3.8 18.4 ± 1.1 19.6 ± 1.8 .25 .66 .47
40 min rewarming 29.9 ± 3.2 34.1 ± 2.3 34.5 ± 2.3 .02 .016* .82
3 h off CPB 32.1 ± 1.2 35.2 ± 1.0 37.5 ± 1.6 .002* .0001* .16
24 h off CPB 34.3 ± 1.9 35.1 ± 1.0 38.0 ± 0.9 .38 .0009* .0048*
Brain temperature (°C)
Baseline 38.3 ± 0.7 37.8 ± 0.8 38.5 ± 0.9 .32 .68 .17
DHCA 16.6 ± 2.0 15.9 ± 1.9 17.9 ± 0.5 .51 .23 .08
40 min rewarming 34.7 ± 0.6 36.9 ± 1.2 37.6 ± 2.3 .04 .01* .49
3 h off CPB 34.0 ± 0.5 36.8 ± 0.3 38.9 ± 1.2 .002* .0001* .001*
24 h off CPB 36.0 ± 2.1 37.9 ± 0.9 40.0 ± 0.6 .05 .0006* .03
Blood pressure (mm Hg)
On CPB 67.2 ± 17.0 63.6 ± 23.0 61.0 ± 6.0 .74 .57 .81
40 min rewarming 82.2 ± 23.1 90.4 ± 11.7 79.8 ± 22.6 .53 .85 .41
3 h off CPB 91.4 ± 11.4 95.4 ± 14.1 88.6 ± 20.9 .70 .79 .51
24 h off CPB 78.6 ± 11.7 77.8 ± 19.1 79.0 ± 7.2 .93 .96 .89
Heart rate (beats/min)
Baseline 154.8 ± 36.7 144.2 ± 15.8 154.4 ± 20.8 .53 .55 .98
3 h off CPB 131.4 ± 12.3 126.4 ± 19.2 146.8 ± 38.7 .77 .37 .24
24 h off CPB 135.4 ± 15.7 163.6 ± 22.9 161.6 ± 23.4 .06 .07 .08
*P < .0167 is statistically significant by ANOVA and Bonferroni.
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Neurobehavioral assessment. Neurologic deficit score
(NDS; 500, brain death; 0, normal) and overall performance
category (OPC; 5, brain death; 1, normal) were used for eval-
uation of neurologic and behavioral deficits and were carried
out by a veterinarian in a blinded fashion. Details of the
method have been described elsewhere.9 The evaluation was
performed on PODs 2, 3, and 4.
Neurohistologic evaluation. Four days after the operation
all animals were killed and their brains were fixed in situ with
4% paraformaldehyde. Histologic scoring (0, normal; 5+,
necrosis) was performed by a neuropathologist blinded to the
experimental protocol.
Statistical analysis. All results are expressed as mean or
percentage ± standard deviation (SD) and analyzed by a sta-
tistical analysis software package (StatView version 4.5;
Abacus Concepts, Berkeley, Calif). Analysis of variance
(ANOVA) and Bonferroni correction for multiple compar-
isons were used to analyze continuous data. Nonparametric
Mann-Whitney U test was used for data analysis when con-
tinuous or normal distribution could not be assumed. With
Bonferroni correction, a P value lower than .0167 was
required to reach statistical significance between individual
groups.
Results
Experimental conditions. The experimental condi-
tions for each group were similar throughout CPB
(Table I). There were no statistically significant differ-
ences with respect to animal size; brain, esophageal,
and rectal temperatures; and hemodynamic parameters
before and after CPB among groups. The different
brain temperatures in each group corresponded to
esophageal temperatures of 33°C, 36°C, and 38.5°C.
Operative results. One animal assigned to group I
had severe hypoxia develop before extubation and died
36 hours after the operation. Autopsy revealed severe
bilateral pneumonia and pleural effusions, likely
caused by aspiration. Another animal in group III was
extremely anemic before the operation and died within
6 hours of the operation of persistent hypotension. All
Table II. Blood analysis
Group I Group II Group III P values 
(mean ±SD) (mean ±SD) (mean ±SD) (ANOVA)
AST (U/L)
Preoperative level 47.2 ± 10.8 56.8 ± 23.4 51.2 ± 22.3 .75
Postoperative level 129.8 ± 48.0 137.4 ± 43.1 163.4 ± 38.5 .46
ALT (U/L)
Preoperative level 28.4 ± 7.6 35.8 ± 6.5 31.2 ± 14.1 .52
Postoperative level 26.2 ± 4.1 30.6 ± 11.9 23.6 ± 15.8 .64
LDH (U/L)
Preoperative level 789.0 ± 168.8 821.2 ± 235.4 876.0 ± 362.3 .88
Postoperative level 1233.2 ± 218.7 1128.2 ± 212.0 1114.0 ± 508.8 .84
ALP (U/L)
Preoperative level 185.6 ± 71.2 215.0 ± 51.0 197.0 ± 68.8 .77
Postoperative level 205.4 ± 33.6 213.4 ± 37.0 226.0 ± 62.5 .78
CK (U/L)
Preoperative level 847.2 ± 538.5 1280.8 ± 912.2 763.4 ± 392.0 .43
Postoperative level 3433.0 ± 1033.3 3212.8 ± 1252.3 2899.2 ± 1757.3 .83
Total bilirubin (mg/dL)
Preoperative level 0.2 ± 0.0 0.3 ± 0.1 0.3 ± 0.2 .38
Postoperative level 0.6 ± 0.1 0.6 ± 0.2 0.4 ± 0.2 .10
BUN (mg/dL)
Preoperative level 11.8 ± 4.1 11.0 ± 3.5 11.0 ± 1.2 .90
Postoperative level 14.6 ± 2.3 13.0 ± 4.5 14.8 ± 5.6 .78
Venous lactate
Baseline 1.8 ± 0.9 2.2 ± 1.5 1.3 ± 0.3 .46
1 h off CPB 6.6 ± 2.0 7.0 ± 2.9 8.3 ± 4.5 .70
WBC
Preoperative level 18.4 ± 2.5 17.0 ± 5.7 18.8 ± 5.7 .84
Postoperative level 28.2 ± 10.9 22.3 ± 6.7 32.7 ± 9.1 .23
Platelet (%)
Preoperative level 665.6 ±287.1 585.6 ± 239.5 583.4 ± 162.3 .82
Postoperative level 548.4 ± 173.8 417.2 ± 99.7 373.6 ± 66.5 .10
AST, Aspartate transaminase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; ALP, alkaline phosphatase; CK, creatine kinase; BUN, blood urea nitro-
gen; WBC, white blood cell count.
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data from these 2 animals were excluded from analysis.
All other 15 animals randomly assigned to the 3 exper-
imental groups survived and were subsequently extu-
bated uneventfully. In 1 animal in group III severe neu-
rologic injury developed; the animal’s condition
progressively deteriorated, and it died after POD 3.
Data from this animal were included in the analysis.
Changes in body weight. There were no differences
with respect to the preoperative body weight among the
3 groups. Subsequent changes in body weight are
expressed as percentage of baseline ± SD. At 3 hours
after discontinuation of CPB, the changes in percentage
body weight were not statistically significant (group I
112.1% ± 4.6%, group II 113.1% ± 4.6%, group III
114.9% ± 3.5%; P = 0.59 by ANOVA). At 24 hours after
the operation, however, there was a significant change in
body weight among groups, with group III animals hav-
ing a significant increase in body weight compared with
group I (group I 109.3% ± 1.7%, group II 113.6% ±
6.3%, and group III 117.9% ± 3.4%; I vs II, P = .13; I vs
III, P = .01; II vs III, P = .14 by ANOVA and Bonferroni
correction). The differences in body weight decreased
with time, and by POD 4 there were no differences
between groups. Indeed, group III animals tended to
have lower percentage body weight before being killed
(group I 104.1% ± 1.1%; group II 104.8% ± 4.3%, and
group III 102.3% ± 5.6%; P = .62 by ANOVA).
Total body water content. The results are expressed
as percentage of baseline ± SD. There were no differ-
ences in BEI among the groups before the operation
and 3 hours after CPB (group I 88.3% ± 13.9%, group
II 88.0% ± 4.8%, and group III 88.4% ± 10.2%; P =
0.99 by ANOVA). At 24 hours group III had a signifi-
cantly lower BEI than did group I, signifying a higher
TBWC (group I 83.9% ± 12.5%, group II 74.0% ±
9.6%, and group III 62.9% ± 10.8%; I vs II, P = .18; I
vs III, P = .01; II vs III, P = .14 by ANOVA and
Bonferroni correction). This difference gradually
diminished with time, and by POD 4 no differences
were seen among groups (group I 82.4% ± 21.8%,
group II 94.8% ± 31.9%, and group III 96.1% ± 21.8%;
P = 0.68 by ANOVA).
Blood analysis. Levels of alanine aminotransferase,
alanine aminotransferase, lactate dehydrogenase, cre-
atine kinase, alkaline phosphatase, total bilirubin, and
blood urea nitrogen were not significantly different
among the 3 experimental groups at baseline and 24
hours after the operation (Table II). Electrolytes,
platelet count, and white blood cell count were not sta-
tistically different among groups, although there was a
tendency toward a higher white blood cell count in
groups I and III. No clinical evidence of infection was
seen in any of these experimental animals throughout
the duration of the study. The hematocrit levels tended
to be higher in groups II and III (hematocrit 29.0%) 24
hours after the operation, despite additional fluid
administration to maintain hematocrit level in the 26%
to 27% range. Nevertheless, no significant differences
were observed among the 3 groups.
Electroencephalographic analysis. The baseline
electroencephalographic morphologic and other char-
acteristics were similar in all groups, and there were
isoelectric brain activities during DHCA (Figs 1 and 2).
One animal in hyperthermic group III had 2 episodes of
seizure activity about 10 hours after the operation (Fig
1). No animals in other groups had electroencephalo-
graphic evidence of seizure. In addition, there was a
remarkable delay in the recovery of neuroelectric activ-
ity in group III, such that the electroencephalographic
amplitude was significantly lower at 14 hours after
DHCA (Fig 2). Nevertheless, none of the animals had
resumed normal baseline electroencephalographic pat-
terns by 48 hours after the operation. There were no
differences in electroencephalographic frequency
among the 3 groups before and after DHCA.
Near-infrared spectroscopic analysis. The NIRS
patterns (oxyhemoglobin, deoxyhemoglobin, cyto-
chrome aa3) were similar in all 3 groups during cooling,
DHCA, and rewarming from CPB (Figs 3, 4, and 5). In
brief, the relative oxyhemoglobin concentration
increased during the cooling period and rapidly
decreased during DHCA. On reperfusion there was a
progressive increase in the oxyhemoglobin signal
toward a steady level (Fig 3). Reciprocal changes were
observed in the deoxyhemoglobin signals in all 3 groups
(Fig 4). The cytochrome aa3 signal briefly decreased
immediately on initiation of CPB and cooling but rapid-
ly declined to a plateau from the onset of DHCA (Fig 5).
During rewarming cytochrome aa3 signals recovered
Fig 1. Representative electroencephalographic tracing of
seizure in a group III hyperthermic animal.
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toward a steady state. No significant differences were
observed between groups with respect to the NIRS sig-
nals during CPB. After discontinuation of CPB, howev-
er, animals in the hypothermic group I had a significant-
ly better recovery of oxyhemoglobin, deoxyhemoglobin,
and cytochrome aa3 levels for at least 3 hours (P = .02,
P = .003, and P = .01, respectively, by repeated-mea-
sures ANOVA). After correction with Bonferroni test,
group I had significantly better preservation of all NIRS
parameters than did group III. In contrast to the other 2
groups, the recovery of oxyhemoglobin and cytochrome
aa3 signals in group III remained below baseline levels,
whereas deoxyhemoglobin values stayed above baseline
levels.
Neurobehavioral assessment (Figs 6 and 7)
Neurologic deficit score. The NDS was highest
(worst) on the first examination at POD 2 and subse-
quently improved in all groups. An exception was the
hyperthermic animal in group III that had neurologic
deterioration and died after POD 3; for statistical pur-
poses the highest possible NDS score was assigned to
this animal on the last day of the study. The NDS was
significantly different among groups on PODs 2 and 3,
but the difference was only marginally significant on
POD 4 because of the large SD attributable to the sin-
gle death in group III (P = .003, P = .04, and P = .051,
Fig 2. Mean electroencephalographic amplitude at baseline and at 14 and 48 hours after the operation. *P < .05,
group I versus group III.
Fig 3. Results of cerebral oxyhemoglobin level by NIRS examination. DPF, Differential path length factor.
*P < .05, group I versus group III.
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respectively, by ANOVA). Specifically, hypothermic
group I animals had a significantly better neurologic
outcome (P = .001 and P = .013 by Bonferroni correc-
tion) than did animals in group III.
Overall performance category. The OPC scoring was
worst on POD 2 but progressively recovered toward
normal in groups I and II. In group III the OPC
remained unchanged or deteriorated with time for all
animals. The OPC scores were significantly different
among groups on PODs 3 and 4 (P = .01 and P = .01,
respectively, by ANOVA). Specifically, hypothermic
group I had a better OPC score than did hyperthermic
group III at 3 and 4 days after the operation (P = .004
and P = .005, respectively, by Bonferroni correction).
Neurohistologic evaluation. Neuropathologic injury
was evaluated as in previous studies (Fig 8).9 Evidence
of hypoxic-ischemic injury was indicated by the pres-
ence of hypereosinophilic shrunken neurons with kary-
orrhectic nuclei. Only the hemisphere contralateral to
the site of temperature probe insertion was scored his-
tologically, however, because the ipsilateral hemisphere
may have had potentially traumatic damage related to
the probe. Two sham-treated animals were subjected to
the insertion of a brain temperature probe followed by
full heparinization that lasted for the duration of exper-
imental protocol. These 2 animals had completely nor-
mal neurobehavioral scores and no histologic injury
found in the contralateral hemisphere after 4 days.
Fig 4. Results of cerebral deoxyhemoglobin level by NIRS examination. DPF, Differential path length factor.
*P < .05, group I versus group III.
Fig 5. Results of cytochrome aa3 level by NIRS examination. DPF, Differential path length factor. *P < .05, group
I versus group III.
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The hypoxic-ischemic histologic injury was mild in
groups I and II, and no statistically significant differ-
ences were seen between these 2 groups. Histologic
scores were significantly worse in the cortical area
between group I versus group III (P = .04 by Mann-
Whitney U test); in the hippocampus between group I
versus group III and group II versus group III (P = .01
and P = .01, respectively); and in the dentate gyrus area
between group I versus group III (P = .047).
Discussion
This study examined the effects of various postis-
chemic cerebral temperature strategies after a period of
DHCA in a survival piglet model. Postischemic hyper-
thermia caused significantly worse recovery of cerebral
hemoglobin oxygenation and the redox state of
cytochrome aa3. Hyperthermia was associated with
persistent deterioration of neurobehavioral outcome.
Fourteen hours after the operation, the electroen-
cephalographic amplitude in hyperthermic animals was
significantly lower than in the other 2 groups. Electro-
encephalographic seizures were seen only in the hyper-
thermic group. Histologic assessment confirmed the
adverse effects of fever and demonstrated severe injury
in the cortical and hippocampal areas. Gains in body
weight and TBWC were significantly greater in ani-
Fig 6. NDS on PODs 2, 3, and 4. *P < .05, group I versus group III.
Fig 7. OPC on PODs 2, 3, and 4. *P < .05, group I versus group III.
788 Shum-Tim et al The Journal of Thoracic and
Cardiovascular Surgery
November 1998
mals subjected to hyperthermia after operation, sug-
gesting diffuse body edema formation. The decreasing
body weight of the group III animals by POD 4 proba-
bly reflected the severity of neurologic impairment that
most of these hyperthermic animals had, which pre-
vented them from drinking.
Postischemic hypothermia (brain temperature 34°C)
resulted in a significantly improved outcome relative to
hyperthermia but not relative to a brain temperature of
37°C. There was, however, a consistent trend toward
improved neurobehavioral and histologic outcomes
with hypothermia. Also, it should be noted that esopha-
geal temperature tended to be 1°C less than brain tem-
perature and rectal temperature 2°C less than brain
temperature.
In the experimental animals the distribution of injury
occurred primarily in the frontal and parietal cortex,
with less damage in the occipital and temporal cortices,
hippocampus, dentate gyrus, and caudate nucleus. This
neuropathologic pattern of neocortical damage was
consistently observed in our laboratory and other stud-
ies with a large-animal model, in contrast to many
other studies in which the hippocampal CA1 region
was reported to be most sensitive to ischemic injury.11
This discrepancy may be attributed to the fact that most
CA1 data were observed in rodent models in which
deep hypothermia and CPB were not used.
The findings of this study have considerable clinical
significance because aggressive surface rewarming has
evolved as a cornerstone of management in stabilizing
neonatal condition in the delivery room and neonatal
intensive care unit, including after cardiac operations.
Furthermore, fever is commonly seen after CPB and is
often left untreated during the early postoperative peri-
od. The findings presented here suggest that these
strategies may exacerbate cerebral injury.
Although actual brain temperature after a global cere-
bral hypoxic-ischemic insult has not been thoroughly
investigated in human beings, there have been a number
of laboratory studies that suggest that hypoxia-ischemia
may alter brain thermal regulation after an insult, to the
detriment of neuronal recovery. Colbourne, Nurse, and
Corbett1 showed in a gerbil model that brain tempera-
ture recorded after transient ischemia was significantly
higher than the median preischemic level, despite main-
tenance of constant ambient temperature. Others have
noted similar postischemic hyperthermia in experimen-
tal animals.2,12 A recent study from our own laboratory
that demonstrated the neuroprotective effect of
oligosaccharide Sialyl Lewisx analog CY-1503 with a
survival piglet model also showed by direct measure-
ment that brain temperature was higher in control ani-
mals after POD 1 (unpublished data). The mechanism
of postischemic cerebral hyperthermia remains unclear.
There is some evidence that certain proinflammatory
cytokines are elevated after hypoxia-ischemia.13 These
cytokines may affect the hypothalamic neurons that reg-
ulate temperature by elevating the thermal set-point.
The implications of this study for the management of
patients not undergoing DHCA remain unclear, although
suggestions of the potential deleterious effect of cerebral
hyperthermia after CPB in the adult population have
Fig 8. Histologic scores for neocortex, hippocampus, dentate gyrus, and caudate nucleus. *P < .05,
group I versus group III. #P < .05, group II versus group III.
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recently been reported.14 In a randomized prospective
study of 150 adult patients undergoing coronary artery
bypass grafting, there was a tendency toward worse neu-
ropsychologic outcome among patients who were
weaned from CPB at a warmer nasopharyngeal temper-
ature.15 These authors reported significantly worse visu-
al reproduction subset of the Weschler memory scale at
3 months if the core temperature was rewarmed above
38°C during weaning from CPB.
Hyperthermia increases cerebral metabolic demands.
If this occurs in the early postischemic period, when
neurons are particularly vulnerable, it may precipitate
neuronal cell death. The NIRS result in this study sup-
ports a hypothesis of early postischemic hypoxic stress.
During the post-CPB phase, the oxyhemoglobin level
was significantly lower and there was a concomitant
increase in deoxyhemoglobin signal in hyperthermic
group III animals. Also, the cytochrome aa3 level was
significantly reduced during the first 3 hours after CPB
in the hyperthermic group with respect to the other 2
groups. The correlation of brain energy levels deter-
mined by magnetic resonance spectroscopy with
cytochrome aa3 measured by NIRS scanning and their
correlation with neurologic outcome have been demon-
strated previously in our laboratory.10
Previous studies have suggested mechanisms other
than hypoxic stress through which hyperthermia exac-
erbates ischemic brain injury. Blood-brain barrier per-
meability is increased by normothermic or hyperther-
mic brain temperature after brain ischemia.16 The
significant increase in body weight and TBWC may
also reflect the potential for severe brain edema in the
hyperthermic group.
Protective effects of mild hypothermia. Many
investigators have demonstrated a significant reduction
in histologic injury in the hippocampal CA1 area with
mild (2°-3°C) postischemic hypothermia in survival
rodent models. Chopp and associates17 found signifi-
cant CA1 preservation after 8 minutes of ischemia in
rats by immediate postischemic cooling for 2 hours to
34°C. Carroll and Beek18 were able to reduce CA1 loss
after ischemia in gerbils at 4 days’ survival by hypo-
thermia applied either immediately or 1 hour after the
insult but not 3 hours after the insult. Coimbra and
Wieloch19 found significant CA1 preservation at 7 days
in rats given 5 hours of delayed postischemic hypother-
mia at 33°C. These authors also showed that a 3.5-hour
cooling period was much less effective than 5 hours,
and 30 minutes was completely ineffective when start-
ed 2 hours after the insult. Although the optimal
hypothermic therapy is not evident from these studies,
it is probable that the neuroprotective effect depends on
the duration of the ischemic insult, the extent and dura-
tion of postischemic hypothermia, and the delay in ini-
tiation after the injury. Mild hypothermia is preferable
because the side effects of cooling became more preva-
lent when the temperature drops below 30°C.
Optimal duration and timing of postischemic
hypothermia. Colbourne and Corbett5 have shown
that increasing the duration of postischemic hypother-
mia at 32°C from 12 hours to 24 hours produced
greater neuroprotection. Nurse and Corbett20 have also
demonstrated neurohistologic protection after several
days of mild hypothermia induced by a pharmacologic
agent.
The timing of initiation of hypothermia is also critical.
A number of animal studies have examined the effect of
different intervals of postischemic normothermic recir-
culation before initiation of hypothermia. These studies
demonstrated that postischemic hypothermia is of great-
est benefit in attenuating the extent of brain injury when
initiated shortly after injury and that efficacy decreases
with increasing delay of initiation.5-7 Colbourne and
Corbett5 have demonstrated a 90% preservation of CA1
neurons and reduced neurologic deficits after 30 days
when 24 hours of hypothermia at 32°C was initiated 1
hour after ischemia, an insult that produced more than
95% cell loss without intervention. They further demon-
strated in a similar study that such intervention provided
persistent neuroprotection after 6 months, although the
protection was less effective than that at 3 months.21 In
studies with a repetitive cerebral ischemic gerbil model,
Shuaib and coworkers6 also suggested that to be effec-
tive hypothermia must be initiated as soon as possible
after the insult, because cooling at 1⁄2 hour or longer after
repetitive injury produced no protection compared with
control subjects.
Mechanisms of postischemic hypothermic neuro-
protection. Indirect evidence indicates that modest
hypothermia (core temperature 30°-31°C) exerts a pro-
tective effect on the development of ischemic edema
and decreases the early postischemic elevation in
leukotriene B4, an arachidonate metabolite related to the
development of edema.22 Ischemia has also been impli-
cated in the inhibition of calcium ion–regulated enzyme
systems such as calcium-calmodulin–dependent protein
kinase II and protein kinase C, which are integrally
involved in mediating neuronal excitability and neuro-
transmitter synthesis and release. Hyperthermia potenti-
ates the reduction in protein kinase C and calcium-
calmodulin–dependent protein kinase II, whereas
modest hypothermia attenuates ischemia-induced inhi-
bition of these important enzyme systems.23,24
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The quantitative relationship between brain tempera-
ture and energy use rate was demonstrated in vivo by
Laptook and associates25 with phosphorus 31 and pro-
ton nuclear magnetic resonance spectroscopy. They
showed that brain temperature correlated inversely
with phosphocreatine and intracellular pH, such that
higher cerebral temperature reduces phosphocreatine
and intracellular pH under nonischemic conditions.
Brain temperature and energy use rate were directly
correlated in a linear fashion. A reduction of brain tem-
perature by 1°C was associated with a decline in ener-
gy use rate of 5.3%, which suggests a potential mecha-
nism for the contribution of modest hypothermia to
neuroprotection in this study. Thoresen and cowork-
ers26 further substantiated this hypothesis with phos-
phorus 31 nuclear magnetic resonance spectroscopy by
showing that postischemic hypothermia significantly
attenuated delayed energy failure for 3 days in piglets
subjected to ischemic injury of the brain. Hypothermia
thus reduces both the cerebral demand needed to sus-
tain electrophysiologic and synaptic activity and the
energy requirement necessary for intrinsic cellular sup-
port and membrane homeostasis.
Free radical–mediated cell damage represents anoth-
er potential mechanism of reperfusion cell injury,
although direct measurement of free radicals is diffi-
cult. Karibe and colleagues27 showed a greater reduc-
tion of the endogenous antioxidants ascorbate and glu-
tathione in rat cortex subjected to normothermic than
hypothermic injury. This suggests higher free radical
activity in the normothermic group.
Conclusions
This study demonstrates the dangers of postinsult
hyperthermia and suggests possible beneficial effects
of mild hypothermia. In light of these findings, the rou-
tine practice of aggressive rewarming and tolerance of
fever in neonates after an insult such as a cardiac arrest
or DHCA should be reconsidered. Maintenance of a
controlled degree of mild hypothermia for as long as 24
hours after any hypoxic-ischemic cerebral insult may
be beneficial for the infant at risk for brain injury.
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Discussion
Dr Julie A. Swain (Lexington, Ky). I congratulate you on
another in a series of investigations answering fundamental
questions in cardiac surgery. You have correlated anatomic,
physiologic, and behavioral parameters in an elegant study.
As Professor Taylor emphasized earlier at this meeting,
most patients undergoing CPB have demonstrated brain ab-
normalities. Those of us performing research on circulatory
arrest models view circulatory arrest as a worst-case subset of
brain injury after cardiac operations. Your study illustrates
how we can use DHCA experiments to help us in all our car-
diac operations.
You have emphasized that the operation is not over when
the bandages are on. We can profoundly influence the ulti-
mate course of patients with modifications of the care in the
intensive care unit. It is well known that there is an ischemic
penumbra (border zone) in the brain and spinal cord that is
vulnerable for some time after the operation. There is no
question that the border zone exists; the question is how long
we have the opportunity to modify the environment.
I have 3 questions. Current investigations question whether
postevent hypothermia simply delays the appearance of
injury. You studied the animals for 4 days, during 1 of which
the animals were hypothermic. Do you think that you might
have missed further injury? Many studies show that apopto-
sis occurs as long as 10 days after ischemia.
My second question asks how the results of this study have
changed the daily practice of clinical medicine in your insti-
tution. Do you keep the patients hypothermic for 24 hours? If
so, at what temperature?
My final question is whether you have considered reanalyz-
ing the Boston Children’s Study data for the effect of postop-
erative systemic temperature on the ultimate neurologic out-
come? Because this study contains a wealth of carefully
collected data, these retrospective results might be interesting.
Again, I congratulate you on an excellent study that will
have wide-ranging implications for the postoperative care of
patients.
Dr Shum-Tim. Your first question was whether postis-
chemic hypothermia actually provided permanent protection
or just delayed neurologic injury. I think, as you mentioned,
that this question creates a difficult logistic problem because
of the expense and the duration of the study and the question
of how to define long-term results in the animals. I can quote
you some of the data available from rodents in which the ger-
bil model was studied for as long 6 months and both neuro-
behavioral and pathologic protection were seen in the rodents
exposed to postischemic hypothermia compared to the con-
trol group. However, it is important to emphasize, even in the
rodent model, that although the 6-month result was signifi-
cantly better than that in the control group there was still sig-
nificant deterioration between 3 months and 6 months.
Furthermore, even if in the worst case hypothermia does not
provide permanent protection but simply delays cerebral
injury, this may nevertheless provide a window of opportunity
for some other resuscitative agents that could be applied,
such as a pharmacologic agent.
Your second question was about what we do clinically. This
study has certainly sensitized my own experience. Since I went
back to Montreal a couple of months ago, we have alerted our
intensive care nurses to pay strict attention to the rectal tem-
perature, especially because the brain temperature is actually
much higher than the esophageal or rectal temperature and we
therefore tend to underestimate the degree of hyperthermia. In
my experience at Boston Children’s we also did that clinically,
and I remember that it is almost an institutional protocol that
none of our patient’s rectal temperature is allowed to go above
38°C immediately after the operation. Particularly with
patients who were in hemodynamically unstable condition or
who had a cardiac arrest and were put on extracorporeal mem-
brane oxygenation, we made an effort to perfuse these patients
under extracorporeal membrane oxygenation at the relatively
lower temperature of 35° to 36°C. This is my personal experi-
ence working with Dr Jonas at Boston Children’s, and I am
sure that investigation will greatly influence my own practice,
and I hope that of my institution.
In response to the last question, we have not gone back to
retrospectively analyze temperature data from the cohort of
patients that Dr Jonas and Dr Newburger described in the
New England Journal of Medicine. I agree that this is an in-
teresting question.
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Dr David A. Murphy (Halifax, Nova Scotia, Canada). It
is a number of years since I qualified in veterinary medicine,
in 1956, to be exact, but at that time we were taught that the
normal pig temperature was 39°C (102.2°F). In your group
III you have said that these piglets were kept at 39°C and des-
ignated them as hyperthermic, but if things have not changed
since 1956 with respect to the normal pig temperature, would
that influence your interpretation of your results? In other
words, are all the pigs in groups I and II hypothermic and are
the group III pigs actually normothermic?
Dr Shum-Tim. If I remember correctly, a temperature as
high as 39°C is acceptable for the lamb. I do not recall in any
of our animal models, at least for the past 3 years that I have
worked with Dr Jonas in the laboratory, a regular temperature
in our piglets as high as 39°C.
Dr Shunji Sano (Okayama, Japan). I think that brain pro-
tection is the major issue in the next century, and I think that
better protection of the brain is to perfuse the brain during
arch repair. For this reason, not only am I but also some of the
Japanese younger surgeons are now using brain perfusion
during arch repair, such as coarctation complex and hypo-
plastic aortic arch repairs, so that we can avoid circulatory
arrest to the brain in older patients. I have done procedures on
more than 20 patients, and we have had no neurologic insult
so far.
My question is whether you checked the electroencephalo-
graphic and also neurologic examination results in the patient
with mild to moderate hypothermia, no use of deep hypother-
mia, and circulatory arrest? For such a patient, do you still
think that it is worthwhile to put the patient in mild hypother-
mia, not normothermia, after the operation?
Dr Shum-Tim. First I would like to emphasize that, as Dr
Swain emphasized earlier, that our model uses the worst pos-
sible insult by creating a long DHCA; however, I am not sure
whether CPB alone can create this kind of injury.
In my own experience, 2 of our patients operated on in the
intensive care unit last week had no circulatory arrest for
tetralogy of Fallot repair at 3 months old and for multiple
ventricular septal defect closure at 3 years old. By the time
we operated on our second patient, we were called by the
intensive care unit to tell us that the temperature had gone up
to 40°C, even though there was not any circulatory arrest.
What is the significance of that for the brain? Does it have the
same implication as after DHCA? I do not know. Even if you
use retrograde cerebral perfusion or other cerebral protection,
I am not sure that we are completely immune from this kind
of a problem.
In our experimental model, in the first 2 groups the elec-
troencephalographic and the neurobehavioral recoveries were
not perfect, particularly in the first 2 days. In view of the fact
that they were in severe DHCA for 100 minutes, I would not
expect them to have normal values; however, I would expect
recoveries to be better than in the hyperthermic group.
Dr Sano. My cerebral perfusion is not retrograde. I do per-
fuse from the innominate artery and use antegrade perfusion
all the time, and I do the whole operation between 25° and
30°C, because the electroencephalographic result is always
normal.
Dr Shum-Tim. In the example I gave of my 2 clinical
patients who had CPB alone, they also had antegrade perfu-
sion, but they also had a temperature of 40°C. I do not know
how we explain that, and I cannot say at this point whether it
has any relationship to DHCA.
Dr Thomas L. Spray (Philadelphia, Pa). This is not by
any means an area of my expertise, but it strikes me that you
really have a model of injury here and that, with a flow rate
of 100 mL/kg/min and warming to 39°C from 25°C, much of
the ischemic damage to the brain may be occurring because
of inadequate flow at high temperatures during the rewarm-
ing period. If you look at your graphs on cytochrome aa3 and
the deoxyhemoglobin curves, much of the changes that were
seen late were already apparent at the end of the rewarming
period and then were relatively stable after that. How do you
know that there is actually ongoing damage after the period
of rewarming?
Dr Shum-Tim. Your point is valid. Hyperthermia may
exacerbate ischemia-reperfusion injury. Unfortunately, we do
not have any practical method to separate these issues. Some
clinical reports in the adult literature have shown a relatively
better neurologic score 3 months down the line in a group of
patients who were warmed less aggressively.
